Form 8-K Filing: Director Appointment and Resignation

On March 12, 2026, Colgate-Palmolive Company announced a change in its Board of Directors. Christopher S. Boerner, Ph.D., CEO and Board Chair of Bristol-Myers Squibb, was elected to the Colgate-Palmolive Board, effective March 15, 2026. Dr. Boerner brings extensive experience in the global biopharmaceutical and healthcare industries. His compensation will follow the company's standard non-employee director program. Additionally, Steven A. Cahillane informed the Board that he will not seek reelection at the upcoming Annual Meeting of Stockholders on May 8, 2026, due to the demands of his new role as CEO of The Kraft Heinz Company.